Surviving Covid-19 with Heparin?

被引：53
|
作者：
ten Cate, Hugo [1 ,2 ,3 ]
机构：
[1] Maastricht Univ, Dept Internal Med, Thrombosis Expertise Ctr, Med Ctr, Maastricht, Netherlands
[2] Cardiovasc Res Inst Maastricht, Maastricht, Netherlands
[3] Gutenberg Univ, Ctr Thrombosis & Hemostasis, Med Ctr, Mainz, Germany
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2021年 / 385卷 / 09期
关键词：
D O I：
10.1056/NEJMe2111151
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：845 / 846
页数：2
相关论文
共 50 条
  • [41] Heparin-Induced Thrombocytopenia in Severe COVID-19
    Daviet, Florence
    Guervilly, Christophe
    Baldesi, Olivier
    Bernard-Guervilly, Fanny
    Pilarczyk, Estelle
    Genin, Adrien
    Lefebvre, Laurent
    Forel, Jean Marie
    Papazian, Laurent
    Camoin-Jau, Laurence
    CIRCULATION, 2020, 142 (19) : 1875 - 1877
  • [42] Therapeutic Anticoagulation with Heparin in Patients with Covid-19 Reply
    Zarychanski, Ryan
    Lawler, Patrick R.
    Goligher, Ewan
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (21): : 2014 - 2014
  • [43] Impact of COVID-19 on monitoring of therapeutic unfractionated heparin
    Adie, Sarah K.
    Farina, Nicholas
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2021, 51 (03) : 827 - 829
  • [44] Potential of heparin and nafamostat combination therapy for COVID-19
    Asakura, Hidesaku
    Ogawa, Haruhiko
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (06) : 1521 - 1522
  • [45] Impact of COVID-19 on monitoring of therapeutic unfractionated heparin
    Sarah K. Adie
    Nicholas Farina
    Journal of Thrombosis and Thrombolysis, 2021, 51 : 827 - 829
  • [46] PULMONARY FIBROSIS IN PATIENTS SURVIVING ARDS PNEUMONIA OF COVID-19 AND NON-COVID-19 ETIOLOGIES
    Sturgill, Jamie
    Mayer, Kirby
    Kalema, Anna
    Dave, Kinjal
    Mora, Stephanie
    Kalantar, Alborz
    Montgomery-Yates, Ashley
    Morris, Peter
    CRITICAL CARE MEDICINE, 2023, 51 (01) : 466 - 466
  • [47] Patients surviving COVID-19 had increased risk for incident diabetes vs. persons without COVID-19
    Montori, Victor M.
    ANNALS OF INTERNAL MEDICINE, 2022, 175 (08) : JC93 - JC93
  • [48] Efficacy of therapeutic-dose heparin for severe COVID-19 patients at COVID-19 Emergency Hospital Jakarta
    Hendarto, Hari
    Akbar, Femmy Nurul
    Buwono, Prasetyo Widhi
    Yasmin, Putri Adara
    Halida, Mega
    Ismail, Efriadi
    Rakhmawati, Nurul
    Tadjoedin, Hilman
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2024, 18 (07): : 1002 - 1009
  • [49] Surviving a Pandemic: The Adaptability and Sustainability of Nonprofit Organizations through COVID-19
    Olawoye-Mann, Salewa
    CANADIAN JOURNAL OF NONPROFIT AND SOCIAL ECONOMY RESEARCH, 2021, 12 (01) : 82 - 85
  • [50] Surviving COVID-19: Biopsychosocial Impacts, Death Anxiety, and Coping Strategies
    Muazzam, Amina
    Naseem, Faiqa
    Shakil, Muneeba
    Visvizi, Anna
    Klemens, Jolanta
    VACCINES, 2023, 11 (03)
12345